Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
arious components such as Antithrombin III, Complement C5, and Factor B were measured at different intensities and fold changes, with a follow-up at 6 months. The study aimed to identify biomarkers associated with Long Covid and recovery.
Finding help can be especially challenging for carers. Please visit the Long Covid symptoms pages to find relief for your loved-ones.
Finding help can be challenging. We hope to break down a barrier by providing relief for various Long Covid symptoms.
Exploring the complexities of Post-Infectious Fatigue Syndromes reveals a landscape where diagnostic criteria overlap, prevalence data is scarce, and core symptoms persist, hinting at a shared pathophysiology underlying chronic disability post-infection.
A study suggests that individuals hospitalized with flu face a heightened risk of long-term health issues, akin to long Covid.
A good practical assessment tool, (app and questionnaire) for long Covid
Researchers investigated immune and hormonal differences in individuals with Long COVID compared to those without. They found significant variations, including higher levels of specific immune cells, stronger antibody responses to SARS-CoV-2 and Epstein-Barr virus (EBV), and lower levels of the stress hormone cortisol in Long COVID patients.
In the face of healthcare disparities and persistent symptoms, LGBTQ+ survivors are forging paths to healing through solidarity, advocacy, and resilience
Doctors share experiences and recommendations on diagnosing, managing, and referring patients with Long COVID
Mitochondria are often referred to as the powerhouse of cells, responsible for producing energy in the form of adenosine triphosphate (ATP) through oxidative phosphorylation. In Long COVID, mitochondrial dysfunction can occur due to various factors, including viral impact, immune system dysregulation, and oxidative stress, leading to impaired energy production and cellular processes.